trial

Research of Anatomo-functional Biomarkers in Schizophrenia

NCTId NCT03996122
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Unknown
Enrollment 15 (estimated)
Sponsored by University Hospital, Caen
Primary completion 2021-04-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
15 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2019-04-04
Primary completion
2021-04-04
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
fMRI

Sponsors

University Hospital, CaenLead Sponsor

Investigators

1
Anaïs Vandevelde, MDPrincipal Investigator

Sites

1 total
Caen, France

Facts & assertions

4 sourced
Enrollment
15
Phase
NA
Primary Completion Date
2021-04-04
Status
UNKNOWN
relationships
The graph out of here
drug
fMRI
drug
lead_sponsor
University Hospital, Caen
company
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Anaïs Vandevelde, MD
person